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Background: The quality of life (QoL) of informal caregivers of people with Parkinson’s disease (PD)
(PwP) can be affected by the caring role. Because of cognitive symptoms and diminished activities of
daily living, in addition to the management of motor symptoms, carers of PwP and cognitive impair-
ment may experience increased levels of burden and poorer QoL compared with carers of PwP without
cognitive impairment. This study aimed to investigate the impact of cognitive impairment in PD upon
QoL of carers.
Methods: Approximately 36months after diagnosis, 66 dyadic couples of PwP and carers completed
assessments. PwP completed a schedule of neuropsychological assessments and QoL measures; carers
of PwP completed demographic questionnaires and assessments of QoL. Factor scores of attention,
memory/executive function and global cognition, as derived by principal component analysis, were
used to evaluate cognitive domains.
Results: Hierarchical regression analysis found lower Montreal Cognitive Assessment was a signiﬁcant
independent predictor of poorer carer QoL, in addition to number of hours spent caregiving, carer
depression and PD motor severity. Attentional deﬁcits accounted for the largest proportion of variance
of carer QoL. Carers of PwP and dementia (n=9) had signiﬁcantly poorer QoL scores compared with
PwP and mild cognitive impairment (n=18) or normal cognition (n=39) carers (p<0.01).
Conclusions:Attentional deﬁcits were the strongest predictor of carer QoL compared with other cognitive
predictors. Carers for those with PD dementia reported the poorest QoL. Interventions such as respite or
cognitive behavioural therapy to improve mood and self-efﬁcacy in carers may improve carer QoL.
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Introduction
Informal carers are a crucial source of support for
individuals with Parkinson’s disease (PD), providing
both physical and emotional support. It is estimated
that informal carers of people with PD (PwP) save,
for example in the UK, over £70000 per person
annually in health and social care costs (Jackson
et al., 2013) compared with formal support.
However, the quality of life (QoL) of these informal
caregivers of PwP is affected by the caring
role (Goldsworthy and Knowles, 2008). Carers of
PwP are often spouses who are themselves elderly
with and may have their own health problems
(Berry and Murphy, 1995). Increased carer strain
has previous been associated with early nursing home
placement for PwP (Abendroth et al., 2012; Goetz
and Stebbins, 1993).
Quality of life is subjective and difﬁcult to
deﬁne (Martinez-Martin, 1998); it includes physical,
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psychological and social elements as well as personal
and cultural context (World Health Organization,
1993). Poor QoL can lead to poor psychosocial
consequences. PD motor severity, falls and neuropsy-
chiatric symptoms in PwP predict poorer QoL in
carers (Aarsland et al., 1999; Abendroth et al., 2012;
Santos-Garcia and de la Fuente-Fernandez, 2015),
reduced social activities, ﬁnancial strain, perceived
strain and emotional health have been associated
with poorer carer QoL (Aarsland et al., 1999;
Leiknes et al., 2010; Schrag et al., 2006). Previous
studies have shown a relationship between QoL in
PwP and the QoL in informal carers (Miyashita
et al., 2011; Peters et al., 2011). Poorer PD QoL may
be a primary stressor for QoL in their carer. Alterna-
tively, there may be a mutually dependent relationship
between carers and PwP, where the biopsychosocial
functioning in one person is dependent on the same
underlying features in the other person (Greenwell
et al., 2015).
Thommessen et al. (2002) suggested that carers of
patients with dementia and carers of PwP experience
similar levels of burden. However, it may be that the
carers of PwP and cognitive impairment, in addition
to caring for motor and non-motor symptoms in
PwP, experience an increased burden. For example,
carers of PwP and cognitive impairment may acquire
additional and unfamiliar household responsibilities
as PwP experience memory problems and challenges
in organizing and decision making, plus personal
and domestic activities of daily living because of
disability. They may also have had to cope with the
emotional impact of watching their partner or
relative decline both physically and cognitively
(Carter et al., 2012). Previous studies have shown
that increased carer burden is greater in PD demen-
tia carers (PDD) carers compared with those with
mild cognitive impairment (PD-MCI) (Leroi et al.,
2012) and that carer burden is associated with be-
havioural problems related to executive dysfunction
(Kudlicka et al., 2014). Furthermore, neuropsychiat-
ric symptoms are more common in PDD and have
also been associated with increased carer burden
(Oh et al., 2015).
This study investigated whether cognitive
impairment in PwP was an additional stressor to
QoL. Furthermore, we investigated whether impair-
ment in particular cognitive domains in PwP were
associated with poorer carer QoL. This could be
potentially useful to guide clinicians as to appropriate
interventions to protect carer QoL, which could
lead to delays in formal care and nursing home
placement.
Methods
Participants
This study is part of the incidence of cognitive im-
pairments in cohorts with longitudinal evaluation in
Parkinson’s disease (ICICLE-PD) study (Yarnall
et al., 2014). Newly diagnosed PD patients from
community and outpatient clinics in Newcastle upon
Tyne and Gateshead were invited to take part in the
study between June 2009 and December 2011. After
baseline assessments, participants were invited back
at 18-month intervals where PwP were subsequently
re-assessed at approximately 18 and 36months
(Lawson et al., 2016). Idiopathic PD was diagnosed
by a movement disorder specialist and fulﬁlled
Queen’s Square Brain Bank criteria (Hughes et al.,
1992). Participants were excluded from ICICLE-PD
at baseline if they had signiﬁcant cognitive impair-
ment at initial assessment (mini-mental state exami-
nation (MMSE) <24) or a diagnosis of dementia
(Emre et al., 2007). Age-sex matched healthy control
subjects (n=99) were recruited to provide normative
data, which has been previously reported by Yarnall
et al. (2014).
Carer assessments were added to the 36-month
evaluation to investigate the wider effects of PD and
cognitive impairment. Informal carers of PwP who
returned at 36months were invited to complete addi-
tional carer assessments (n=66). Informal carers were
spouses, partners, adult family members or friends
who were the primary caregiver of PwP. The study
was approved by the Newcastle and North Tyneside
Research Ethics Committee. All subjects provided
written informed consent.
Carer assessments
Demographic information of carers was collected,
including age, sex, education and hours per week
caregiving. The Hospital Anxiety and Depression Scale
(HADS) subscales (Zigmond and Snaith, 1983) were
used to measure anxiety and depression; higher scores
indicated more severe symptoms. Neuropsychiatric
symptoms and carer distress were measured by the
Neuropsychiatric Inventory (NPI) and NPI Carer
Distress (NPI-D) (Cummings et al., 1994).
Carer QoL was measured by the Scale of Quality of
Life of Care-Givers (SQLC) (Glozman et al., 1998),
which is a PD speciﬁc measure of QoL in carers. The
scale gives a total score ranging from 4–149; lower
scores indicate poorer QoL.
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Clinical and neuropsychological assessments in
patients
Patient demographic information, including age, sex
and education was collected. PwP completed the
Movement Disorder Society (MDS) Uniﬁed
Parkinson’s Disease Rating Scale (UPDRS) Part III
(Goetz et al., 2008) and the Geriatric Depression Scale
(GDS-15) (Yesavage et al., 1982). Subjects were
assessed in an ‘on’ motor state. Levodopa equivalent
dose was calculated for all dopaminergic medications
using methods described by Tomlinson et al. (2010).
The Parkinson’s Disease Questionnaire (PDQ-39)
summary index was used as a global measure of QoL
in PwP and is well validated (Jenkinson et al., 1997)
and is a recommended measure of QoL in PD by the
MDS task force (Martinez-Martin et al., 2011). The
scores ranged from 0 (best possible QoL) to 100
(worst possible QoL).
People with Parkinson’s disease completed a sched-
ule of neuropsychological tests as described previously
(Yarnall et al., 2014). In brief, global cognitive func-
tion was assessed using the MMSE (Folstein et al.,
1975) and Montreal Cognitive Assessment (MoCA)
(Nasreddine et al., 2005). Attention was measured
using power of attention and digit vigilance accuracy
from the Cognitive Drug Research battery (Nicholl
et al., 1995). Memory was assessed using the number
of correct answers from pattern recognition memory
and spatial recognition memory, and mean trials to
success for paired associate learning from the
Cambridge Neuropsychological Test Automated
Battery (Robbins et al., 1994). Executive function
was assessed using the one touch stockings from the
Cambridge Neuropsychological Test Automated
Battery, phonemic ﬂuency (number of word generated
in 60s beginning with the letters F, A and S) and
semantic ﬂuency (number of animals generated in
90s). Visuospatial function was evaluated using the
pentagon copying item within the MMSE, graded
using a modiﬁed 0–2 rating scale (Ala et al., 2001).
Language was assessed using the naming (0–3) and
sentence (0–2) items in the MoCA.
People with Parkinson’s disease were classiﬁed as
having mild cognitive impairment if they performed
two standard deviations (SD) below the means
of appropriate norms (controls) on at least two
neuropsychological tests across the ﬁve cognitive
domains in addition to subjective cognitive impair-
ment (Litvan et al., 2012). Recent studies have
suggested 2 SD may be a suitable cut-off to distinguish
PD-MCI from Parkinson’s disease-normal cognition
(PD-NC) (Goldman et al., 2013; Lawson et al.,
2014). PDD was diagnosed using the MDS criteria
(Emre et al., 2007).
Statistical analysis
Statistical analyses were performed using SPSS software
(Version 22.0; SPSS, Armonk, NY: IBM Corp). Data
were examined for normality of distribution with
visual histograms and Kolmogorov–Smirnov’s test.
Comparisons of means between two groups were per-
formed using independent t-tests or Mann–Whitney
U-test as required. For more than two group compar-
isons, one way ANOVAs or Kruskal–Wallis tests were
used as appropriate. Multiple comparisons were
corrected using Bonferroni’s correction. Correlations
were assessed using Spearman’s rho. Principal
component analysis (PCA) using oblique oblimin
rotation was used to reduce the large number neuro-
psychological assessments to a smaller number of
cognitive dimensions, which has been previously
described by (Lawson et al., 2016). Factor scores were
then calculated using the component score coefﬁcient
matrix at baseline and 36months. Hierarchical
regression models were used to build predictive
models of QoL. Backwards stepwise regression was
used to determine a basic model predicting SQLC.
Variables included in the model were carer age,
gender, years of education, hours per week caregiving,
Hospital Anxiety and Depression Scale-Anxiety
subscale and Hospital Anxiety and Depression
Scale-Depression subscale. Age of PwP, UPDRS III,
Levodopa equivalent dose, GDS-15, NPI, NPI-D and
PDQ-39 were also included. Cognitive measures of
PwP were then separately added to the model to
determine whether cognition was an added stressor
to carer QoL.
Results
At 36months, 66 dyadic couples of informal carers
and PwP carers (n=66) had a mean age of
67±11.5 years with a range of 32 years to 85years
(Table 1). Eighty-one percent of carers were female,
and 70% were retired.
Characteristics of patients with Parkinson’s disease
In total, 110 PwP of 158 returned for 36month
evaluation; 44 PwP did not have carers as they were
independent or their relatives did not describe
themselves as a carer and so did not complete the
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questionnaires. Signiﬁcant differences at 36months
between PwP with and without carers are described in
Table 2. There was no signiﬁcant difference in the
proportion of PD-MCI between the two groups,
although all PDD subjects had a carer (n=9).
Neuropsychological test scores of PwP and carers at
baseline and 36months are described in Table 3.
PCA reduced baseline neuropsychological tests into
three principal components: memory/executive
function (paired associated learning, paired recogni-
tion memory, spatial recognition memory and one
touch stockings), attention (power of attention and
digit vigilance) and global cognition (MMSE, MoCA,
verbal ﬂuency and semantic ﬂuency) accounting for
40%, 12% and 10% of the variance, respectively.
Factor scores were calculated using baseline and
36-month data (Table 3).
Cognitive impairment in Parkinson’s disease and quality
of life in carers
There was a signiﬁcant relationship between PDQ-39
score in the PwP and SQLC scores in the carer
(ρ=0.48, p<0.01) where poorer QoL in PwP was
associated with poorer QoL in the carer. Lower MoCA
scores in the PwP at 36months were moderately
associated with lower SQLC scores (ρ=0.40,
p<0.01). Examining the factor scores from the
PCA analysis at 36months, SQLC score and attention
Table 1 Carer demographic characteristics
Mean SD I-Q range
Carer age (years) 67.1 11.5 14
Education (years) 12.2 2.8 4
Years known participant 46.2 15.0 15
Time as a carer (months) 23.5 24.5 36
Hours per week as caregiver 50.5 69.1 108
n %
Gender, female 55 81
Relationship to care recipient
Spouse or partner 63 93
Daughter 2 3
Other relative 1 2
Friend 2 3
Employment status, retired 41 70
Other caregiving responsibilities 19 28
Children 4 6
Grandchildren 12 18
Other relative 3 4
n = 57, n = 9 coded as missing data: the questionnaire was introduced
later in the study (n = 4) and not completed by carer (n = 5);
SD = standard deviation, I-Q = inter-quartile range.
Table 2 Clinical and demographic characteristic of participants with and without carers
No carer (n = 42) Carer (n = 66)
t/Z pMean SD Mean SD
Age (years) 66.1 10.6 71.3 9.0 2.6 0.010
MDS-UPDRS III 37.5 14.7 39.6 12.4 1.0 0.339
Hoehn and Yahr stage 2.2 0.4 2.2 0.5 0.0 0.984
GDS-15 2.7 2.7 2.9 2.4 0.8 0.447
LED (mg/day) 499.1 305.5 526.3 258.8 0.8 0.411
PDQ-39 SI 20.7 15.9 23.7 17.1 0.9 0.363
MoCA 26.3 3.9 25.4 4.0 1.7 0.095
MMSE 28.3 1.9 27.9 2.7 0.1 0.887
n % n % χ2 p
Gender (male) 22 52 50 76 10.9 0.001
Marital status
Married/living with partner 19 45 64 97 24.4 <0.001
Widowed 10 24 2 3 5.3 0.021
Divorced 6 14 0 0 – –
Single 7 17 0 0 – –
ADL, not independent 5 12 24 36 7.8 0.005
Cognitive classification
PD-MCI 12 29 18 27 1.2 0.273
PDD 0 0 9 14 – –
MDS-UPDRS III =Movement Disorders Society-Uniﬁed Parkinson’s Disease Rating Scale Part III; GDS-15 =Geriatric Depression Score;
LED=Levodopa equivalent dose; PDQ-39 SI = Parkinson’s Disease Questionnaire Summary Index Score; MoCA =Montreal Cognitive Assess-
ment; MMSE =Mini Mental State Examination; ADL = activities of daily living; PD-MCI =mild cognitive impairment in Parkinson’s disease using
two standard deviation cut-off; PDD=Parkinson’s disease dementia; SD, standard deviation.
Signiﬁcant differences highlighted in bold.
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had the strongest association (ρ=0.51, p<0.01);
memory/executive function (ρ=0.47, p<0.01) and
global cognition (ρ=0.43, p<0.01) were also signiﬁ-
cantly correlated.
There were no signiﬁcant differences between
carers in the cognitive groups at 36months in terms
of age, anxiety, depression, sleep quality or physical
health (Table 4, p>0.05 for all). There was also no
signiﬁcant difference in carer rated NPI or NPI-D
scores. There was a threefold difference in hours per
week caregiving PDD carers compared with PD-NC
or PD-MCI (Table 4, p<0.01 for both), but not
between PD-NC and PD-MCI carers. A similar
pattern was found for QoL, where between group
differences were signiﬁcant (p<0.05 for both), but
SQLC score of PDD carers was signiﬁcantly higher
than PD-NC and PD-MCI carers (p<0.01), who did
not differ from each other.
Predicting carer quality of life
Backwards stepwise regression showed that increased
hours spent caregiving (β=0.5); carer depression
Table 3 Neuropsychological test scores of patients with Parkinson’s disease and carers at baseline and 36-month assessments
Baseline 36months Paired differences (36months-baseline)
Z p-valueMean SD Mean SD Mean SD
MoCA 25.1 3.6 25.4 4.0 0.3 3.0 0.4 0.669
MMSE 28.6 1.2 27.9 2.7 0.7 2.1 2.3 0.021
PoA 1356.5 218.3 1484.8 320.1 119.5 281.0 4.4 0.000
Digit vigilance 91.5 13.9 88.8 15.5 2.8 12.1 1.5 0.127
PRM 19.8 2.7 19.2 3.6 0.6 2.8 1.8 0.075
SRM 15.5 2.1 13.8 2.5 1.8 2.6 4.8 0.000
PAL 2.0 0.7 2.4 1.2 0.4 0.9 3.3 0.001
OTS 13.8 3.9 12.2 5.8 1.6 4.2 2.6 0.008
Phonemic fluency 33.6 11.1 35.1 13.7 1.5 10.3 1.0 0.321
Semantic fluency 20.6 6.1 19.8 7.4 0.8 6.7 1.3 0.184
Factor scores
Memory/executive function 0.00 1.09 0.15 1.13 0.13 0.68 0.9 0.373
Attention 0.03 0.99 0.13 0.99 0.04 0.77 0.4 0.664
Global cognition 0.01 0.92 0.16 1.07 0.11 0.67 0.8 0.396
SD = standard deviation; MoCA =Montreal Cognitive Assessment; MMSE =Mini Mental State Examination; PoA = power of attention;
PRM= paired recognition memory; SRM= spatial recognition memory; PAL = paired associated learning, OTS = one touch stockings.
Memory/executive function comprises PRM, SRM, PAL and OTS; attention comprises PoA and digit vigilance; global cognition comprises MoCA,
MMSE, phonemic ﬂuency and semantic ﬂuency.
Signiﬁcant differences highlighted in bold.
Table 4 Comparison of carer questionnaires between cognitive groups
PD-NC PD-MCI PDD
χ2 p
(n = 39) (n = 18) (n = 9)
Mean SD Mean SD Mean SD
Carer Age 65.7 13.6 70.2 6.5 67.3 11.2 0.8 0.672
Time caregiving (hours/week) 37.8 63.0 35.2 61.0 123.6 64.0 10.9 0.004 a, b
SQLC 115.6 12.9 109.8 14.2 88.8 21.2 13.1 0.001 a, b
HADS-A 5.2 4.2 4.3 4.5 6.0 5.3 1.0 0.611
HADS-D 3.2 2.7 3.1 3.9 6.3 3.8 4.8 0.092
NPI total 7.5 7.5 9.6 11.6 14.6 13.1 1.7 0.429
NPI carer distress total 4.0 4.3 5.1 6.6 6.8 6.9 1.0 0.645
Sleep quality 60.6 21.3 60.9 24.9 52.8 23.3 0.6 0.757
Total number health problems 2.0 2.0 1.9 1.8 1.6 1.5 0.3 0.880
Post hoc Bonferroni correction for three group comparisons at p< 0.0167; a = PD-NC versus PD-PDDI; b = PD-MCI versus PDD.
PD-NC=Parkinson’s disease-normal cognition; PD-MCI =mild cognitive impairment in Parkinson’s disease using the two standard deviation cut-off;
PDD=Parkinson’s disease dementia; SD= standard deviation; SQLC= Scale of Quality of Life of Care-Givers; HADS-A =Hospital Anxiety and
Depression Scale-Anxiety subscale; HADS-D=Hospital Anxiety and Depression Scale-Depression subscale; NPI =Neuropsychiatric Inventory.
Signiﬁcant differences highlighted in bold.
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(β=0.2) and PD motor severity (β=0.3) predicted
poorer SQLC scores (p<0.05 for all). The model
accounted for 54% variance (adjusted R2=0.54,
p<0.01).
Cognitive performances of the PwP were individu-
ally added to the basic model to determine their con-
tribution to carer QoL. To determine whether global
cognitive impairment was an additional stressor to
carer QoL, 36-month MoCA score was added to the
basic model (Table 5). Poorer MoCA score of the
PwP was a signiﬁcant predictor of poorer carer QoL
and improved the basic model by 4% (R2=0.04,
p<0.05).
To determine whether impairments in speciﬁc do-
mains predicted carer QoL, factor scores at 36months
were added to the basic model (Table 5). The factor
scores accounted for 11% of the total variance
(R2=0.11, p<0.01); however, only attention was a
signiﬁcant predictor (p<0.05). Repeating the analysis
with memory/executive function and global cognition
removed as non-signiﬁcant factors, showed poorer at-
tention scores in PwP predicted poorer carer QoL and
accounted for 9% of the total SQLC variance
(R2=0.09, p<0.01).
Baseline cognition and carer quality of life at 36months
As a secondary analysis, we examined the associa-
tion between baseline cognition in PwP and carer
QoL at 36months. SQLC score was moderately
correlated with baseline MoCA score (ρ=0.34,
p<0.05), baseline memory and executive function
(ρ=0.48, p<0.01) and baseline attention (ρ=0.40,
p<0.01), but not baseline general cognition
(ρ=0.16, p>0.05). Regression analysis using base-
line predictors of PwP was performed; signiﬁcant
predictors in the basic model were PwP age
(β=0.5), UPDRS III score (β=0.9) and GDS-
15 score (β=1.2). The model accounted for 34%
variance (adjusted R2=0.34, p<0.01). Baseline
MoCA score was a signiﬁcant predictor of future
SQLC score (R2=0.09, β=1.6, p<0.01). Baseline
factor scores were not signiﬁcant predictors of
SQLC at 36months (memory and executive function
β=3.7; attention β=3.2; general cognition β=2.4;
p>0.05 for all).
Discussion
This is the ﬁrst study to investigate the impact of
cognitive function in PwPs upon carer QoL in a large
incident group. This study demonstrated that
cognitive impairment in PwP was an additional
stressor to carer QoL and that impaired attention in
particular contributed to carer QoL. Previous studies
have found associations between cognition and carer
burden (Kudlicka et al., 2014; Leroi et al., 2012;
Martinez-Martin et al., 2008), which contributes to
QoL. A study by Martínez-Martín et al. (2005) found
a correlation between cognitive state, as measured by
the Short Portable Mental State Questionnaire, and
carer QoL, albeit with less comprehensive neuropsy-
chological assessments.
Patient MoCA score, a frequently used clinical
measure of global cognition, was a signiﬁcant predic-
tor of carer QoL, indicating that carers of PwP who
scored poorly on the MoCA were more likely to report
worse. Previous studies have shown poorer cognition,
Table 5 Regression coefﬁcients and model ﬁt of cognitive predictors of SQLC scores
β t p
95% CI for β
Lower bound Upper bound
Basic model† + MoCAa 0.3 2.2 0.030 0.1 1.9
Basic model† + Factor scoresb
Memory/Executive function factor score 0.23 1.54 0.130 1.03 7.72
Attention factor score 0.25 2.02 0.049 0.01 7.97
Global cognition factor score 0.02 0.12 0.906 3.78 4.25
Basic model† + Attention factor scorec 0.4 3.9 <0.001 3.0 9.5
†Additional covariates in each model = hours caregiving, HADS-D and UPDRS III.
SQLC=Scale of Quality of Life of Care-Giver; CI = conﬁdence interval; MoCA=Montreal Cognitive Assessment; HADS-D=Hospital Anxiety and
Depression Scale-Depression Subscale, UPDRS III =MovementDisorders Society-Uniﬁed Parkinson’s Disease Rating Scale Part III; SE, standard error.
aR = 0.82, R2 = 0.68, adjusted R2 = 0.65, SE = 10.4, ΔR2 = 0.04
bR = 0.87, R2 = 0.76, adjusted R2 = 0.72, SE = 9.3, ΔR2 = 0.11
cR = 0.86, R2 = 0.73, adjusted R2 = 0.71, SE = 9.5, ΔR2 = 0.09
Signiﬁcant differences highlighted in bold.
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as measured by the MMSE, in PwP to be associated
with poorer physical health of their carer, increased
stress and higher psychosocial burden (Aarsland
et al., 1999). However, such measures may not be a
sufﬁciently sensitive to capture the different domains
of cognitive impairment in PD (Litvan et al., 2012).
There is a paucity of studies investigating whether
cognitive phenotype in PwP may affect carer QoL.
Using PCA analysis, we found that factor scores for
attention, memory/executive function and global cog-
nition were also signiﬁcantly associated with carer
QoL. However, only poorer attention was a signiﬁcant
predictor of carer QoL; this suggests that attentional
deﬁcits may play a role in reduced carer QoL. It has
been suggested that attentional deﬁcits of PDD
patients are detrimental to basic and instrumental
activities of daily living in PwP (Bronnick et al.,
2006). This includes physical activities, as well as social
interactions including participating in conversations,
keeping appointments and engagement in leisure
activities. Speculatively, carers may have to compen-
sate for the effects of attentional impairments in PwP
by increasing their caring responsibilities, which may
reduce their QoL (Abendroth et al., 2012).
This study demonstrates that QoL among carers
was worse for those who cared for someone with
PDD compared with carers of an individual who was
deemed to be PD-NC or PD-MCI. No signiﬁcant
differences in carer QoL scores were observed between
carers for those with PD-NC and PD-MCI. These
results are comparable with the ﬁndings of Leroi
et al. (2012), who reported that carer burden was
signiﬁcantly higher in PDD carers compared with
PD-NC or PD-MCI carers, although they did not
assess carer QoL.
Almost two-thirds of PwP in this study had an in-
formal carer at their 36-month evaluation. Those
without carers tended to be younger, female and had
no spouse or partner (widowed, divorced or single).
Carers tended to be spouses and were predominantly
women in their late 60s. The demographics of carers
and care recipients in this study are similar to previous
reports (Glozman, 2004; Peters et al., 2011; Santos-
Garcia and de la Fuente-Fernandez, 2015).
Carer QoL was also signiﬁcantly associated with PD
disease motor severity and the number of hours spent
caregiving per week. Severity of PD has been associ-
ated with carer burden and strain in previous studies
(Santos-Garcia and de la Fuente-Fernandez, 2015),
but not directly to carer QoL, as in our study. The
number of hours spent caregiving has previously been
reported to affect carer well-being and distress, while
increased frequency of carer breaks may be protective
(Goldsworthy and Knowles, 2008). Carer depression
was predictive of poorer carer QoL; previous studies
have generally focussed on depression in the PwP,
with only a few researchers evaluating the effect of
depression among carers (Martínez-Martín et al.,
2007). Therefore, these results highlight the impor-
tance of assessing depressive symptoms in the carer,
as well as in the PwP.
The strengths of this study include the range of
validated instruments, the comprehensive schedule of
neuropsychological tests and the variety of carer
measures. A minority of carers did not complete all
measures, which may have reduced the power of the
statistical analysis. Thus, subtle differences or associa-
tions may not have been detected. The cross-sectional
nature of this study was also a limitation; as these
measures were introduced approximately 3 years after
diagnosis, no causal relationships could be deter-
mined. Although the SQLC was designed for carers
of PwP and has good internal consistency (Glozman
et al., 1998), QoL is difﬁcult to measure because of
variation in deﬁnitions and subjectivity between
individuals (Glozman, 2004). PD-MCI criteria have
not yet been validated; we used a more conservative
2 SD cut-off to increase diagnostic certainty of
PD-MCI, although previous studies have shown that
both 1.5 SD and 2 SD are suitable (Goldman et al.,
2013; Wood et al., 2016). Furthermore, some PwP
did not return for the 36-month evaluation; these
may have been of greatest interest as their carers may
experience more strain, burden or poorer QoL.
Baseline motor severity of PwP was poorer in
participants who did not return at 36months;
however, there were no other signiﬁcant differences
between those who returned and those who did not
(Supplementary Table 1). Finally, protective factors
were not accounted for in this study which may
mitigate the negative factors, for example coping styles
(Greenwell et al., 2015).
Conclusion
This study demonstrates an association between
cognitive impairment in PwP and poorer carer QoL.
Carers of those with PDD reported the poorest QoL.
Attentional deﬁcits in PwP were the strongest predic-
tor of carer QoL compared with other cognitive
predictors. Our results suggest that respite to reduce
the number of hours per week spent caregiving may
be readily implemented means of improving carer
QoL. However, respite care can be difﬁcult to access
because of low availability and reduced funding
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(Laverty et al., 2016). Interventions to improve cogni-
tion in PwP may improve both patient (Lawson et al.,
2016) and carer QoL. Carers of PwP and cognitive
impairment may beneﬁt from cognitive behavioural
therapy or acceptance and commitment therapy,
which have been effected for dementia caregivers
(Losada et al., 2015). Further research is needed to
substantiate these ﬁndings, particularly to determine
the longitudinal impact and potential protective fac-
tors of carer QoL. Longitudinal studies should also
consider the cognitive changes in carers and consider
the impact this has on both the carer and the PwP,
and other outcomes such as nursing home placement.
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Key points
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predictors.
• Respite and cognitive behavioural therapy to
improve mood and self-efﬁcacy in carers may
improve carer quality of life.
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